Session Type: Poster Session (Sunday)
Session Time: 9:00AM-11:00AM
Background/Purpose: Greater emphasis has been placed on cost saving measures due to ballooning healthcare cost in the U.S. ACGME now evaluates trainee ability to practice cost conscious care through the systems based practice competency. In the rheumatology clinic at Walter Reed National Military Medical Center (WRNMMC), we observed inappropriate ordering of the so called “lupus panel.” The “lupus panel” lab is better known as the lupus anticoagulant test (LAC), which may be associated with the antiphospholipid syndrome (APS) and its clinical features of thromboembolic events and recurrent pregnancy loss. We suspected the misleading name led physicians to order the “lupus panel” to screen for systemic lupus erythematosus (SLE) rather than to evaluate for APS. We retroactively evaluated the rate and cost of inappropriate ordering of the “lupus panel” and found thousands of dollars spent annually on inappropriate ordering. The lab name was changed from “lupus panel” to “lupus anticoagulation panel” based on our recommendation. We then set out to evaluate a change in ordering pattern and resulting cost over a three month period.
Methods: Results of the “Lupus Panel” from 1 January 2015 – 31 December 2015 were collected. The rationale for ordering each test was analyzed in the EMR by two rheumatologists. The test was considered inappropriate if it was ordered for anything other than thrombophilia, initial SLE evaluation by a rheumatologist, or pregnancy loss. The name of the lab was changed to “Lupus Anticoagulant Panel” on 1 April 2018. The ordering pattern from 1 April 2018 – 30 June 2018 was similarly evaluated. The lab processing cost, excluding labor, was estimated by our lab manager. Fisher’s exact test was utilized to evaluate the association between lab name and ordering pattern.
Results: 403 “lupus panel” lab tests were processed in the National Capital Region in 2015, at a rate of 33.6 per month. 148 (37%) samples were considered inappropriate, costing $4,722.68 ($393.56 per month) to process. The three most common reasons for inappropriate testing were musculoskeletal complaints 63 (43%), fatigue 13 (8%), and paresthesias 6 (4%). 65 LAC tests were ordered in the first three months after the name change, at a rate of 22.3 per month. Of the 62 tests that had sufficient documentation to analyze, 14 were considered inappropriate (22.6%). The most common reasons for inappropriate testing were musculoskeletal complaints 6 (43%) and rash 5 (36%). The monthly cost of inappropriate lab tests was $147.79.
Conclusion: Inappropriate ordering of the “lupus panel” cost WRNMMC approximately $4,722.68 in lab processing for the calendar year 2015. Changing the name of the lab to better describe the test yielded a significant reduction in the percentage of inappropriate lab tests (37% vs 22.6%, p=0.0318) and reduced annual and monthly cost by approximately $2,949.20 and $245.77, respectively.
To cite this abstract in AMA style:Anderson C, Stitt R, O'Brian R. Naming Is Everything! the Cost of Inappropriate “Lupus Panel” Testing [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/naming-is-everything-the-cost-of-inappropriate-lupus-panel-testing/. Accessed February 26, 2020.
« Back to 2019 ACR/ARP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/naming-is-everything-the-cost-of-inappropriate-lupus-panel-testing/